Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price was down 1.4% during mid-day trading on Tuesday . The stock traded as low as $1.90 and last traded at $1.90. Approximately 3,686,589 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 25,609,648 shares. The stock had previously closed at $1.93.
Tilray Stock Performance
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The stock has a 50-day moving average price of $1.80 and a 200-day moving average price of $1.89. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of -4.23 and a beta of 2.19.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business had revenue of $229.90 million during the quarter, compared to the consensus estimate of $226.20 million. During the same quarter last year, the company posted ($0.15) EPS. The firm’s revenue was up 24.8% on a year-over-year basis. As a group, analysts forecast that Tilray Inc will post -0.12 earnings per share for the current year.
Institutional Investors Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
- Five stocks we like better than Tilray
- Top Biotech Stocks: Exploring Innovation Opportunities
- Advance Auto Parts Eyes Long-Term Growth Despite Q2 Hurdles
- How to Invest in Small Cap StocksĀ
- Toll Brothers Stock Up on Q3 Beat: Luxury Homes Drive Growth
- Stock Market Upgrades: What Are They?
- 4 No-Brainer Stocks to Hold This Fall for Steady Gains
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.